Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis (Q46846924)

25 December 2017

title

Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis (English)

1 reference

25 December 2017

positron emission tomography

main subject

1 reference

10

1 reference

25 December 2017

author name string

Hiroshi Ohira

1

1 reference

25 December 2017

Ichizo Tsujino

2

1 reference

25 December 2017

Shinji Ishimaru

3

1 reference

25 December 2017

Noriko Oyama

4

1 reference

25 December 2017

Toshiki Takei

5

1 reference

25 December 2017

Eriko Tsukamoto

6

1 reference

25 December 2017

Masatake Miura

7

1 reference

25 December 2017

Shinji Sakaue

8

1 reference

25 December 2017

Nagara Tamaki

9

1 reference

25 December 2017

publication date

15 December 2007

1 reference

25 December 2017

European Journal of Nuclear Medicine and Molecular Imaging

published in

1 reference

25 December 2017

volume

35

1 reference

25 December 2017

issue

5

1 reference

25 December 2017

page(s)

933-941

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1007/s00259-007-0650-8

exact match

0 references

cites work

Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0650-8

Clinicopathological study of fatal myocardial sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0650-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0650-8

21 January 2018

Myocardial sarcoidosis

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0650-8

Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0650-8

Two-dimensional echocardiographic findings in systemic sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0650-8

Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0650-8

Positron emission tomography predicted recovery of complete A-V nodal dysfunction in a patient with cardiac sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0650-8

Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0650-8

Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0650-8

Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0650-8

Images in cardiology. Cardiac sarcoidosis in a 60 year old woman

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0650-8

Images in cardiovascular medicine. Multimodality imaging of cardiac sarcoidosis before and after steroid therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0650-8

Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0650-8

Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0650-8

Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0650-8

The use of 2-[18F]fluoro-2-deoxy-D-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0650-8

Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: comparison with stress thallium imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0650-8

Cardiovascular magnetic resonance of acute myocardial infarction at a very early stage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-007-0650-8

Cardiac sarcoidosis. Diagnosis with endomyocardial biopsy and treatment with corticosteroids

21 January 2018

1 reference

12 December 2020

Artifactual inhomogeneities in myocardial PET and SPECT scans in normal subjects

1 reference

12 December 2020

A unique presentation of cardiac sarcoidosis

1 reference

12 December 2020

Holter Monitoring as a Noninvasive Indicator of Cardiac Involvement in Sarcoidosis

1 reference

12 December 2020

Combination of 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in assessing cardiac sarcoidosis.

1 reference

12 December 2020

Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function

1 reference

12 December 2020

Cardiac sarcoidosis: reversion of myocardial perfusion abnormalities by dipyridamole

1 reference

12 December 2020

Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET.

1 reference

12 December 2020

Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies

1 reference

12 December 2020

Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis

1 reference

12 December 2020

Changes in the peripheral vasculature of various organs in patients with sarcoidosis--possible role of microangiopathy

1 reference

12 December 2020

Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography

1 reference

12 December 2020

Images in cardiovascular medicine. Cardiac sarcoidosis evaluated by delayed-enhanced magnetic resonance imaging.

1 reference

12 December 2020

Cardiac sarcoidosis: spectrum of MRI features

1 reference

12 December 2020

Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study

1 reference

12 December 2020

ECG abnormalities in patients with sarcoidosis

1 reference

12 December 2020

MR findings of myocardial sarcoidosis

1 reference

12 December 2020

Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans

1 reference

12 December 2020

Steroid therapy in cardiac sarcoidosis. Increased left ventricular contractility concomitant with electrocardiographic improvement after prednisolone

1 reference

12 December 2020

Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis

1 reference

12 December 2020

Lipoprotein lipase, hepatic lipase and plasma lipolytic activity. Effects of heparin and a low molecular weight heparin fragment (Fragmin).

1 reference

12 December 2020

10.1007/S00259-007-0650-8

Identifiers

DOI

1 reference

25 December 2017

1 reference

25 December 2017